Multi Plan Corp MPLN
We take great care to ensure that the data presented and summarized in this overview for MultiPlan Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MPLN
View all-
H&F Corporate Investors Viii, Ltd. San Francisco, CA216MShares$2.52 Billion100.0% of portfolio
-
Leonard Green & Partners, L.P. Los Angeles, CA38.4MShares$449 Million0.32% of portfolio
-
Ares Management LLC Los Angeles, CA30MShares$350 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.8MShares$290 Million0.0% of portfolio
-
Cpv Partners, LLC Stamford, CT19.8MShares$231 Million10.88% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.52MShares$111 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny8.43MShares$98.4 Million0.0% of portfolio
-
Nomura Holdings Inc Tokyo, M08MShares$93.4 Million0.01% of portfolio
-
Barclays PLC London, X07.01MShares$81.9 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA6.35MShares$74.2 Million0.0% of portfolio
Latest Institutional Activity in MPLN
Top Purchases
Top Sells
About MPLN
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment and revenue integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Insider Transactions at MPLN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 14
2024
|
Tiffani Misencik SVP, Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,328
+50.0%
|
-
|
Aug 07
2024
|
William B. Mintz SVP, Corp. Affairs/Strategy |
BUY
Open market or private purchase
|
Direct |
197,000
+8.2%
|
$0
$0.4 P/Share
|
Aug 07
2024
|
Travis Dalton Pres., Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500,000
+9.08%
|
$0
$0.37 P/Share
|
Aug 06
2024
|
William B. Mintz SVP, Corp. Affairs/Strategy |
BUY
Open market or private purchase
|
Direct |
81,165
+3.88%
|
$0
$0.31 P/Share
|
Aug 06
2024
|
Douglas Michael Garis EVP, CFO & Treasurer |
BUY
Open market or private purchase
|
Direct |
1,150,000
+10.51%
|
$0
$0.31 P/Share
|
Aug 05
2024
|
Douglas Michael Garis EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,571,428
+50.0%
|
-
|
Aug 05
2024
|
William B. Mintz SVP, Corp. Affairs/Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
1,928,571
+50.0%
|
-
|
May 16
2024
|
Anthony Colaluca Jr Director |
BUY
Open market or private purchase
|
Indirect |
160,000
+42.11%
|
$0
$0.6 P/Share
|
Apr 24
2024
|
Michael Stuart Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,413
+35.01%
|
-
|
Apr 24
2024
|
Richard A Clarke Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,413
+35.01%
|
-
|
Apr 24
2024
|
Anthony Colaluca Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,413
+31.21%
|
-
|
Apr 24
2024
|
Glenn R August Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,413
+35.01%
|
-
|
Apr 24
2024
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,413
+35.16%
|
-
|
Apr 24
2024
|
John Michael Prince Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,413
+44.71%
|
-
|
Apr 24
2024
|
Julie D Klapstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,413
+34.24%
|
-
|
Mar 29
2024
|
Jeffrey Doctoroff EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,781
-0.18%
|
$0
$0.81 P/Share
|
Mar 29
2024
|
Michael Kim SVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,510
-0.2%
|
$0
$0.81 P/Share
|
Mar 29
2024
|
Gerald Kozel SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,958
-0.27%
|
$0
$0.81 P/Share
|
Mar 29
2024
|
Dale A. White Executive Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
20,120
-0.13%
|
$0
$0.81 P/Share
|
Mar 11
2024
|
Jerome Hogge EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,041,667
+50.0%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 15.6M shares |
---|---|
Open market or private purchase | 2.09M shares |
Payment of exercise price or tax liability | 1.21M shares |
---|